Moleculin Biotech is trading at $0.49 (+10.56%) amid broader market strength after July CPI matched expectations, reducing immediate rate-hike concerns.
- No verified company-specific announcement dated August 12, 2026 was identified.
- The Nasdaq Composite rose 0.63%, supporting risk appetite across growth-oriented stocks.
- Recent financing and MIRACLE-trial news remain background volatility factors, not confirmed catalysts today.